Yutaka Yamamoto

16PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Software quality, processes and metricsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 29, 2026
Transcriptionally Informed Nucleosome Profiling of Circulating Cell-Free DNA Predicts Breast Cancer Recurrence.

|Mar 28, 2026
Overcoming Trastuzumab-Pertuzumab Resistance and Optimizing Sequential Anti-HER2 Therapy in HER2-Positive Metastatic Breast Cancer.

Yutaka Yamamoto

|Jan 24, 2025
Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.

Yutaka Yamamoto, Hiroji Iwata, Shigehira Saji

|Oct 08, 2024
Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors.

Tomomi Nishimura, Ravi Velaga, Norikazu Masuda

|May 12, 2024
Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.

Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama

|Apr 03, 2024
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.

Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama

Pageof 3

Frequent Collaborators

4 joint publications

Masato Takahashi

4 joint publications

Norikazu Masuda

3 joint publications

Naruto Taira

3 joint publications

Masakazu Toi